Citigroup’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $138K | Buy |
39,405
+23,904
| +154% | +$98K | ﹤0.01% | 4162 |
|
|
2025
Q4 | $52.2K | Sell |
15,501
-4,718
| -23% | -$12.3K | ﹤0.01% | 4557 |
|
|
2025
Q3 | $26.5K | Sell |
20,219
-45,917
| -69% | -$47.5K | ﹤0.01% | 4721 |
|
|
2025
Q2 | $47.4K | Sell |
66,136
-44,030
| -40% | -$34.6K | ﹤0.01% | 4787 |
|
|
2025
Q1 | $162K | Sell |
110,166
-185,795
| -63% | -$443K | ﹤0.01% | 4313 |
|
|
2024
Q4 | $1.31M | Buy |
295,961
+109,788
| +59% | +$445K | ﹤0.01% | 3155 |
|
|
2024
Q3 | $767K | Buy |
186,173
+1,505
| +0.8% | +$8.09K | ﹤0.01% | 3461 |
|
|
2024
Q2 | $1.2M | Sell |
184,668
-763,042
| -81% | -$5.4M | ﹤0.01% | 2774 |
|
|
2024
Q1 | $8.25M | Buy |
947,710
+585,710
| +162% | +$7.11M | 0.01% | 1359 |
|
|
2023
Q4 | $4.14M | Sell |
362,000
-67,788
| -16% | -$671K | ﹤0.01% | 1715 |
|
|
2023
Q3 | $4.14M | Buy |
429,788
+8,137
| +2% | +$79.7K | ﹤0.01% | 1545 |
|
|
2023
Q2 | $4.49M | Sell |
421,651
-161,276
| -28% | -$1.73M | ﹤0.01% | 1554 |
|
|
2023
Q1 | $6.13M | Buy |
582,927
+91,514
| +19% | +$1.03M | ﹤0.01% | 1386 |
|
|
2022
Q4 | $6.09M | Sell |
491,413
-164,581
| -25% | -$1.87M | ﹤0.01% | 1373 |
|
|
2022
Q3 | $6.8M | Buy |
655,994
+251,371
| +62% | +$2.85M | ﹤0.01% | 1369 |
|
|
2022
Q2 | $4.67M | Buy |
404,623
+310,252
| +329% | +$3.65M | ﹤0.01% | 1581 |
|
|
2022
Q1 | $1.19M | Sell |
94,371
-322,112
| -77% | -$3.69M | ﹤0.01% | 2800 |
|
|
2021
Q4 | $4.86M | Buy |
416,483
+88,336
| +27% | +$1.08M | ﹤0.01% | 1857 |
|
|
2021
Q3 | $4.29M | Sell |
328,147
-210,044
| -39% | -$2.71M | ﹤0.01% | 1930 |
|
|
2021
Q2 | $6.93M | Buy |
538,191
+102,084
| +23% | +$1.17M | ﹤0.01% | 1667 |
|
|
2021
Q1 | $4.88M | Buy |
436,107
+331,151
| +316% | +$3.5M | ﹤0.01% | 1804 |
|
|
2020
Q4 | $1.2M | Buy |
104,956
+67,318
| +179% | +$737K | ﹤0.01% | 3360 |
|
|
2020
Q3 | $339K | Sell |
37,638
-112,281
| -75% | -$1.12M | ﹤0.01% | 4190 |
|
|
2020
Q2 | $1.55M | Buy |
149,919
+40,971
| +38% | +$419K | ﹤0.01% | 3110 |
|
|
2020
Q1 | $1.1M | Buy |
108,948
+61,210
| +128% | +$719K | ﹤0.01% | 3068 |
|
|
2019
Q4 | $636K | Sell |
47,738
-218,463
| -82% | -$2.41M | ﹤0.01% | 4203 |
|
|
2019
Q3 | $2.29M | Buy |
266,201
+228,615
| +608% | +$2.22M | ﹤0.01% | 2712 |
|
|
2019
Q2 | $412K | Buy |
37,586
+29,008
| +338% | +$325K | ﹤0.01% | 4605 |
|
|
2019
Q1 | $97K | Sell |
8,578
-211,491
| -96% | -$2.36M | ﹤0.01% | 5768 |
|
|
2018
Q4 | $1.91M | Buy |
220,069
+191,056
| +659% | +$2.19M | ﹤0.01% | 2722 |
|
|
2018
Q3 | $449K | Sell |
29,013
-2,429
| -8% | -$38.4K | ﹤0.01% | 4413 |
|
|
2018
Q2 | $504K | Sell |
31,442
-82,744
| -72% | -$1.22M | ﹤0.01% | 4093 |
|
|
2018
Q1 | $1.48M | Sell |
114,186
-72,095
| -39% | -$898K | ﹤0.01% | 2886 |
|
|
2017
Q4 | $2.34M | Buy |
186,281
+26,371
| +16% | +$344K | ﹤0.01% | 2518 |
|
|
2017
Q3 | $2.11M | Sell |
159,910
-10,216
| -6% | -$141K | ﹤0.01% | 2604 |
|
|
2017
Q2 | $2.69M | Buy |
170,126
+64,309
| +61% | +$934K | ﹤0.01% | 2276 |
|
|
2017
Q1 | $1.51M | Sell |
105,817
-314,459
| -75% | -$4.3M | ﹤0.01% | 2761 |
|
|
2016
Q4 | $5.38M | Buy |
420,276
+278,565
| +197% | +$3.52M | ﹤0.01% | 1755 |
|
|
2016
Q3 | $1.88M | Buy |
141,711
+88,610
| +167% | +$1.04M | ﹤0.01% | 2564 |
|
|
2016
Q2 | $581K | Sell |
53,101
-77,568
| -59% | -$758K | ﹤0.01% | 3494 |
|
|
2016
Q1 | $1.2M | Buy |
130,669
+93,310
| +250% | +$770K | ﹤0.01% | 3118 |
|
|
2015
Q4 | $362K | Sell |
37,359
-77,063
| -67% | -$745K | ﹤0.01% | 4198 |
|
|
2015
Q3 | $999K | Buy |
114,422
+68,908
| +151% | +$643K | ﹤0.01% | 3089 |
|
|
2015
Q2 | $460K | Sell |
45,514
-9,197
| -17% | -$107K | ﹤0.01% | 3779 |
|
|
2015
Q1 | $733K | Sell |
54,711
-27,187
| -33% | -$357K | ﹤0.01% | 3372 |
|
|
2014
Q4 | $1.05M | Buy |
81,898
+49,570
| +153% | +$567K | ﹤0.01% | 3078 |
|
|
2014
Q3 | $351K | Buy |
32,328
+634
| +2% | +$7.26K | ﹤0.01% | 3808 |
|
|
2014
Q2 | $407K | Sell |
31,694
-49,808
| -61% | -$542K | ﹤0.01% | 3602 |
|
|
2014
Q1 | $841K | Sell |
81,502
-13,779
| -14% | -$155K | ﹤0.01% | 3014 |
|
|
2013
Q4 | $927K | Buy |
95,281
+71,803
| +306% | +$645K | ﹤0.01% | 3254 |
|
|
2013
Q3 | $233K | Buy |
23,478
+19,114
| +438% | +$188K | ﹤0.01% | 4033 |
|
|
2013
Q2 | $37K | Buy |
+4,364
| New | +$52.9K | ﹤0.01% | 5550 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Citigroup's IRWD Position: Q1 2026 in Review
Citigroup increased its Ironwood Pharmaceuticals (IRWD) stake by 154% in Q1 2026, buying an estimated $98K and bringing the position to 39,405 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4162.
Citigroup first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.25M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Citigroup held 39,405 shares of Ironwood Pharmaceuticals worth $138K as of Q1 2026.
- Citigroup bought 23,904 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $98K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4162 holding.
- Citigroup first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Ironwood Pharmaceuticals position peaked at $8.25M in Q1 2024.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.